Rabeprazole Sodium Enteric Coated 20 mg + Itopride HCI (SR) 150 mg Capsules (Each Hard Gelatin Capsules)

Rabeprazole Sodium Enteric Coated 20 mg + Itopride HCI (SR) 150 mg Capsules (Each Hard Gelatin Capsules) is a hard gelatin capsule formulated with Rabeprazole Sodium 20 mg + Itopride HCI (SR) 150 mg (Each ). The listed active ingredient profile is Rabeprazole Sodium; Itopride HCI, placing the product in the gastrointestinal / acid-peptic therapy category. The formulation contains acid-suppressive and/or prokinetic components used in selected gastrointestinal conditions. The source indicates sustained release; enteric coated characteristics, which should be retained exactly because release technology can affect administration and product performance. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.